Vesalius Therapeutics is a startup based in the United States, most recent round Series A, 1 tracked investor.
Vesalius Therapeutics is a startup founded in 2021 based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Vesalius Therapeutics is a biotechnology company focused on precision drug development for common diseases such as heart failure, type II diabetes, Alzheimer’s disease, and obesity using AI, machine learning, and genomics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.